SRZN
Surrozen, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
23.93
▲ 0.43 (1.83%)
MARKET · —
Price
Open
23.73
Prev close
23.50
Day high
25.01
Day low
23.49
Volume
148.41K
Market cap
$281.97M
P/E (TTM)
—
52W range
10.73 – 35.00
Trailing performance
Returnvs SPY
1W
+0.13%
+1.5%
1M
+13.37%
+9.6%
3M
-11.44%
-14.5%
6M
-9.78%
-20.8%
YTD
+6.15%
-6.1%
1Y
+108.61%
+88.6%
3Y
+162.19%
+88.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$281.97M
Enterprise value$186.24M
Revenue (TTM)$11.51M
Gross profit$-23.07M
EBITDA$-44.13M
Net income$-324.56M
EPS (TTM)$-40.06
Free cash flow$-21.75M
Total cash$102.04M
Total debt$6.32M
Book value / share$-18.60
Shares outstanding11.75M
Float4.62M
Short % of float17.62%
Dividend yield—
Beta (5Y)0.56
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.73
PEG ratio—
Price / sales—
Price / book—
EV / revenue16.18
EV / EBITDA-4.22
Gross margin-200.38%
Operating margin-207.40%
Profit margin0.00%
Return on equity—
Return on assets-25.39%
Debt / equity—
Current ratio12.14
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $3.48M | $10.65M | $0 | $12.50M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$242.03M | -$63.56M | -$43.04M | -$36.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$242.03M | -$63.56M | -$43.04M | -$36.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -1.26 | -2.10 | -66.8% |
| Mar 2026 | -0.72 | -4.63 | -542.5% |
| Dec 2025 | -1.24 | -9.62 | -678.8% |
| Sep 2025 | -1.17 | -3.60 | -208.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -1.32 | 3 | $373.80K | -62.0% |
| Next quarter | -0.98 | 3 | $373.80K | -29.2% |
| Current year | -9.14 | 1 | $10.75M | +209.1% |
| Next year | -4.19 | 3 | $1.50M | -86.1% |
Analyst targets & ownership
Mean target$44.60
High target$51.00
Low target$40.00
Implied upside86.38%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy0 / 6
Hold0
Sell / Strong sell0 / 0
Held by insiders3.14%
Held by institutions104.84%
Institutions holding94
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-132.54K
Net selling
Buy transactions
10
200.60K shares
Sell transactions
4
333.14K shares
Net transactions
+14
Buys less sells
Sell : buy shares
1.7 : 1
Mixed
Insider-held shares
368.71K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 22, 26 | TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security |
SELL | 325.00K | $6.91M | Indirect |
| Jun 15, 26 | WILLIAMS CHARLES O Chief Operating Officer |
STOCK | 1.67K | $38.55K | Direct |
| Jun 15, 26 | PARKER CRAIG C Chief Executive Officer |
STOCK | 1.62K | $37.53K | Direct |
| Jun 15, 26 | LI YANG Officer |
STOCK | 1.67K | $38.55K | Direct |
| Jun 15, 26 | MALEKI ANDREW PEDRUM Chief Financial Officer |
STOCK | 607 | $11.54K | Direct |
| May 4, 26 | WILLIAMS CHARLES O Chief Operating Officer |
SELL | 2.04K | $67.87K | Direct |
| May 4, 26 | PARKER CRAIG C Chief Executive Officer |
SELL | 4.52K | $150.80K | Direct |
| May 4, 26 | LI YANG Officer |
SELL | 1.58K | $52.80K | Direct |
| May 1, 26 | WILLIAMS CHARLES O Chief Operating Officer |
— | 5.63K | — | Direct |
| May 1, 26 | PARKER CRAIG C Chief Executive Officer |
— | 12.50K | — | Direct |
| May 1, 26 | LI YANG Officer |
— | 4.38K | — | Direct |
| Mar 31, 26 | LI YANG Officer |
STOCK | 1.67K | $0 | Direct |
| Mar 24, 26 | TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security |
BUY | 121.88K | $3.01M | Indirect |
| Mar 16, 26 | TCG CROSSOVER GP II, L.L.C Beneficial Owner of more than 10% of a Class of Security |
BUY | 49.00K | $1.22M | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
COLUMN GROUP III GP, L.P |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
KUTZKEY TIM |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
LI YANG |
Officer | 19.58K | Stock Award(Grant) |
MALEKI ANDREW PEDRUM |
Chief Financial Officer | 607 | Stock Award(Grant) |
PARKER CRAIG C |
Chief Executive Officer | 18.18K | Stock Award(Grant) |
TCG CROSSOVER GP II, L.L.C |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
WILLIAMS CHARLES O |
Chief Operating Officer | 18.24K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
24.13
-0.83% from price
SMA 20
22.79
+5.28% from price
SMA 50
23.08
+3.94% from price
SMA 100
25.72
-6.96% from price
SMA 200
23.56
+1.85% from price
EMA 12
23.63
+1.26% from price
EMA 26
23.24
+2.97% from price
EMA 50
23.53
+1.70% from price
RSI (14)
54.9
Neutral
MACD (12,26,9)
0.39
Hist 0.13
ATR (14)
1.80
7.52% of price
Realised vol 30D
71.9%
Annualised
Bollinger upper
26.52
20, 2σ
Bollinger lower
19.06
20, 2σ
50 / 200 cross
Death
23.08 vs 23.56
Trend bias
Above 200
+1.85%
Risk profile
Beta vs SPY
1.40
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
71.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.7%
Peak to trough
Max drawdown 5Y
-97.2%
Peak to trough
ATR 14
1.80
7.52% of price
Beta (reported)
0.56
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
William Blair Initiates Surrozen at Outperform
MT Newswires · 2d ago
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · 16d ago
Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
MarketBeat · 31d ago
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire · 38d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.